MentionFox
Home › Layoffs › Pacific Biosciences Of California, Inc.
SEC filings · Form 8-K, Item 2.05

Pacific Biosciences Of California, Inc. layoffs and restructuring

Before you join, sell to or invest in Pacific Biosciences Of California, Inc.

MentionFox check on Pacific Biosciences Of California, Inc.: no red flags found in 6 sources; 1 item to note (checked 15 November 2026). mentionfox.com/c/layoffs/pacific-biosciences-of-california

  • Note: Layoff plan disclosed Aug 2026 (about 40 employees) (filing)

Check Pacific Biosciences Of California, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Pacific Biosciences Of California, Inc.?

Every exit or restructuring plan Pacific Biosciences Of California, Inc. reported on Form 8-K under Item 2.05: the filing's own words on employees affected, share of workforce, locations, charges and timing.

About 40 employees are affected, about 8% of its workforce, according to Pacific Biosciences Of California, Inc.'s latest layoff filing, on August 5, 2026. As of November 15, 2026, Pacific Biosciences Of California, Inc. has reported 4 exit or restructuring plans to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, August 5, 2026).

10 companies announced layoffs this week, 1 had other signals.

Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.

UPWORK, INCannounced layoffs
PVH CORP. /DE/announced layoffs
Battellefiled a layoff notice for 15 employees
TidalHealth Primary Carefiled a layoff notice for 5 employees
Phunware, Inc.announced layoffs
Check one company free All companies that announced layoffs this week

EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE) also filed stake reports on 1 other company ↓

Is this your company?

Owed money by them or selling to them? See the free Snapshot of Pacific Biosciences Of California, Inc.

Watch Pacific Biosciences Of California, Inc.: email me the next time it files something

Free to see. No signup.

People from Pacific Biosciences Of California, Inc. who say they are open to work

Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.

Loading the list…

Affected by the Pacific Biosciences Of California, Inc. layoff? Add yourself to the open-to-work list, free
SEC filings4
Latest, employees40
Latest filing2026-08-05

Pacific Biosciences Of California, Inc. reported 4 exit or restructuring plans on Form 8-K under Item 2.05, 1 of 4 stating how many employees or positions are affected. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.

Did Pacific Biosciences Of California have layoffs in 2026? What its filings say

Pacific Biosciences Of California, Inc. (CIK 1299130) reported 4 exit or restructuring plans to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.

Form 8-K filed 2026-08-05

Employees affected

These restructuring actions are expected to result in a workforce reduction of approximately 40 employees, or approximately 8% of the Company's workforce, as the Company aligns its organizational structure with its strategic priorities.

Expected charges

Including the Reduction in Force and related non-headcount cost actions, the Company expects to reduce its annualized operating expenses by $30 million to $40 million by the end of 2027.

Timing

The Company expects that the Reduction in Force will be completed and that these charges will be incurred in the third quarter of 2026.

Form 8-K filed 2025-04-09

Expected charges

On April 9, 2025, the Company announced a plan to reduce its annualized non-GAAP operating expense run rate costs of approximately $45 million to $50 million.

Form 8-K/A filed 2024-08-07

Locations

At this time, the Company expects to incur charges related to the Expense Reduction Plan to be approximately $27 million in fiscal 2024, consisting primarily of the following: approximately $10 million of compensation and benefits afforded to terminated employees; approximately $12 million associated with the closure of the San Diego office and related costs, including lease related costs; and approximately $4 million of charges for excess inventory due to a decrease in internal demand relating to the expense reduction initiatives.

Timing

The Company expects to recognize substantially all of these charges in the second and third quarter of fiscal 2024.

Form 8-K filed 2024-04-16

Expected charges

On April 16, 2024, the Company announced a plan to reduce its annualized run-rate operating expenses on a non-GAAP basis by $50 million to $75 million by the end of 2024 in relation to the Company's prior guidance of 5% operating expense growth.

Also on the record for Pacific Biosciences Of California, Inc.

DateRecordFigureOur pageSource
November 9, 2026Stake report, Schedule 13G, by THE GOLDMAN SACHS GROUP, INC.7.6% of the class5%+ stakesSource
November 6, 2026Stake report, Schedule 13G, by T. Rowe Price Associates, Inc.10.8% of the class5%+ stakesSource
November 4, 2026Leadership change: Bill Meyer appointed, Chief Accounting Officer—Leadership changesSource
August 14, 2026Stake report, Schedule 13G/A, by ARK Investment Management LLC9.59% of the class5%+ stakesSource
August 5, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
July 9, 2026Leadership change: Christopher M. Smith departs, Director—Leadership changesSource
March 27, 2026Stake report, Schedule 13G/A, by The Vanguard Group—5%+ stakesSource
March 6, 2026Leadership change: Michele Farmer departs, Chief Accounting Officer, and 1 more—Leadership changesSource
March 5, 2026Leadership change: Christopher Gibson appointed, Director, and 1 more—Leadership changesSource
February 3, 2026Stake report, Schedule 13G/A, by ARK Investment Management LLC12.34% of the class5%+ stakesSource
November 14, 2025Stake report, Schedule 13G/A, by Gregory Boyd Penner2.8% of the class5%+ stakesSource
November 4, 2025Stake report, Schedule 13G/A, by ARK Investment Management LLC10.3% of the class5%+ stakesSource

Keep reading

More on Pacific Biosciences Of California, Inc. and the records around it.

Pacific Biosciences Of California, Inc. elsewhere on the record

Companies that share a holder

What do you want to do with Pacific Biosciences Of California, Inc.?

Want the whole picture on Pacific Biosciences Of California, Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Pacific Biosciences Of California, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Pacific Biosciences Of California, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    15 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 14 records.

Tools for this story

Each opens in a new tab, filled in for Pacific Biosciences Of California, Inc.. With no account yet, you sign up free and land on the result.

Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.

Where this comes from

Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.

A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.

Cite this page

Permanent URL: https://mentionfox.com/layoffs/pacific-biosciences-of-california
Last updated 2026-11-15
Pacific Biosciences Of California, Inc. layoffs and restructuring: 4 SEC filings, latest about 40 employees (2026-08-05). MentionFox, 2026-11-15. https://mentionfox.com/layoffs/pacific-biosciences-of-california